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Definition: 
Targeted resequencing of those regions transcribed to mRNA. 
 
 History: 
- 2014: publication of the report detailing the design and 
performance of a whole exome sequencing (WES) enrichment 
assay for the dog: the exome -1.01 
- 2015: release of updated canine annotation2  
     => development of 2 novel WES desigsn: 
• Exome-CDS 
• Exome-plus 
Exome-1.0 Exome-CDS Exome-plus 
Ensembl Genes   (excl. UTR)  
RefSeq Genes    
Novel Broad genes2   (excl. UTR)  
mRNA    
microRNAs    
long non-coding 
RNAs2 
   
Antisense 
transcripts2 
   
Candidate CDS 
transdecoder 
   
Number of regions 203,059 244,543 242,914 
Design: 




Reads (in million) Sequencing 
depth (x) Total Mapped Duplicate Remaining (%) 
1.0 90 86 6 80 (88.2%) 101.6 
plus 243 226 14 212 (87.2%) 68.3 
Probe design: Roche Nimblegen SeqCap EZ Developer 
 
Sequencing: 
- Exome-1.0: 8 dogs, 2 captures (HiSeq 2500 PE 100 bp) 
- Exome-plus: 16 dogs, 4 captures (NextSeq 500 PE 75 bp)  
- Capture = 4 pre-capture pooled, barcoded Illumina libraries  






Exome-1.0 Exome-CDS Exome-plus 
fully covered regions (%) 84.9 85.4 79.7 
base pairs covered (%) 90.2 93.4 95.1 
% on target (%) 90.4 - 75.8 
reproducibility regions (%) 79.9 71.4 63.5 
reproducibility base pairs (%) 87.4 87.7 90.4 
non-reference variants (n) 61,820 117,442 266,857 
Due to probe design settings: 
- Exome-plus: up to 20 matches allowed 
- Exome-1.0: only unique probes were allowed 
=> increases the number of target regions and 
target base pairs being sequenced at the 
expense of a lower % reads on target 
Due to average region size:  
614 bp (exome-plus) vs 
260 bp (exome-1.0)  
Conclusion: 
- Overall: cost-efficient direct sequencing approach 
- User-specific customization options 
- Exome-1.0: the core set of protein coding genes 
- Exome-plus, exome-CDS: contain many regulatory regions  
added value for complex diseases where mutations 
influencing expression are more likely to be involved2 
- Exome-plus: most comprehensive design 
- Exome-CDS balances completeness and cost-efficiency 
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